Stoke Therapeutics Inc. (STOK)
NASDAQ · Healthcare
Stoke Therapeutics Inc. Net Income 2022–2025
Stoke Therapeutics Inc. annual/quarterly net income history and growth rate from 2022 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Stoke Therapeutics Inc. net income for the quarter ending March 31, 2026 was -50.0 M, a 144.30% decrease year-over-year.
- Stoke Therapeutics Inc. net income for the twelve months ending March 31, 2026 was 1.0 M, a 101.02% decrease year-over-year.
- Stoke Therapeutics Inc. annual net income for 2025 was -6.9 M, a 92.26% decrease from 2024.
- Stoke Therapeutics Inc. annual net income for 2024 was -89.0 M, a 15.01% decrease from 2023.
- Stoke Therapeutics Inc. annual net income for 2023 was -104.7 M, a 3.59% increase from 2022.
- Stoke Therapeutics Inc. annual net income for 2022 was -101.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Stoke Therapeutics Inc. Net Income — FAQ
Stoke Therapeutics Inc. (STOK) net income over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
What is Stoke Therapeutics Inc.'s net income?
Stoke Therapeutics Inc. (STOK) reported net income of -$7M for fiscal 2025.
Where can I see STOK's net income history?
The chart and table above show Stoke Therapeutics Inc.'s net income by year and by quarter, including the growth rate.